Dr Agarwals Eye Hospital Ltd
₹5163
+15 (0.29%)
Sun, 25 Oct 2026, 10:05 am
Health Services
Medical/Nursing Services
24.5KDr Agarwals Eye Hospital Enterprise Value (EV)
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 18.20 | 15.40 | 138.68 | 42.25 | 46.55 | 20.26 | 14.68 | 10.34 | 13.90 | 10.31 | 2440 | 19.22 | 41.60 | 14.33 | 6.56 | 0 | 14.25 | 11.65 | 31.46 | 34.85 |
| Price to book ratio | 2.16 | 1.84 | 2.19 | 1.35 | 2.40 | 3.60 | 1.79 | 2.08 | 1.81 | 2.47 | 3.91 | 4.80 | 8.04 | 3.75 | 1.60 | 2.69 | 4.39 | 3.80 | 9.28 | 9.09 |
| Price to sales ratio | 0.80 | 0.89 | 0.53 | 0.19 | 0.28 | 0.40 | 0.23 | 0.30 | 0.30 | 0.50 | 0.68 | 0.95 | 1.84 | 1.01 | 0.51 | 1.05 | 1.71 | 1.60 | 4.57 | 4.80 |
| Price to cash flow ratio | 6.31 | 20.28 | 0 | 2.91 | 2.99 | 6.29 | 3.01 | 3.94 | 3.95 | 5.73 | 6.68 | 8.17 | 16.99 | 7.77 | 2.52 | 4.66 | 6.24 | 6.32 | 16.12 | 20.85 |
| Enterprise value | 10.87Cr | 19.85Cr | 41.91Cr | 41.86Cr | 54Cr | 68.64Cr | 48.07Cr | 55.06Cr | 58.3Cr | 83.75Cr | 120Cr | 161Cr | 298Cr | 190Cr | 143Cr | 193Cr | 508Cr | 635Cr | 1693Cr | 2213Cr |
| Enterprise value to EBITDA ratio | 8.39 | 5.23 | 9.86 | 4.36 | 4.72 | 5.17 | 4.06 | 4.31 | 4.56 | 5.49 | 7.53 | 6.84 | 12.19 | 6.33 | 2.98 | 6.14 | 8.62 | 8.28 | 18.19 | 18.28 |
| Debt to equity ratio | 0.36 | 0.48 | 2.26 | 3.11 | 3.14 | 2.62 | 2.18 | 1.82 | 1.47 | 1.13 | 1.33 | 0.78 | 0.52 | 0.52 | 1.07 | 1.24 | 2.47 | 2.05 | 1.71 | 1.59 |
| Return on equity % | 0 | 16.21 | 1.54 | 3.26 | 5.21 | 18.95 | 12.97 | 21.83 | 14.05 | 26.67 | 0.16 | 27.78 | 20.83 | 29.55 | 26.91 | -2.60 | 36.29 | 38.56 | 34.28 | 29.80 |
Dr Agarwals Eye Hospital Ltd Enterprise Value
The Dr Agarwals Eye Hospital Ltd Enterprise Value is a key financial metric used by investors to evaluate Dr Agarwals Eye Hospital Ltd's valuation, profitability, and overall financial performance. Tracking the Dr Agarwals Eye Hospital Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Dr Agarwals Eye Hospital Ltd (NSE: , BSE: 526783) is currently trading at ₹5163, with a market capitalization of ₹2498.6Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Dr Agarwals Eye Hospital Ltd Enterprise Value is essential for fundamental analysis.
Dr Agarwals Eye Hospital Ltd Enterprise Value Current Value
The current Dr Agarwals Eye Hospital Ltd Enterprise Value stands at 2213Cr.
The latest Dr Agarwals Eye Hospital Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Dr Agarwals Eye Hospital Ltd Enterprise Value Historical Trend
The Dr Agarwals Eye Hospital Ltd Enterprise Value has shown the following historical trend:
- 2025: 2213Cr
- 2024: 1693Cr
- 2023: 635Cr
- 2022: 508Cr
- 2021: 193Cr
The recent rise in Dr Agarwals Eye Hospital Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Dr Agarwals Eye Hospital Ltd Enterprise Value Indicates for Investors
The Dr Agarwals Eye Hospital Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Dr Agarwals Eye Hospital Ltd.
Dr Agarwals Eye Hospital Ltd Enterprise Value Analysis Summary
The Dr Agarwals Eye Hospital Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Dr Agarwals Eye Hospital Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Dr Agarwals Eye Hospital Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
